AIM
PFE icon

AIA Investment Management’s Pfizer PFE Stock Holding History

AIA Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.61M Buy
46,289
+32,491
+235% +$1.14M 0.37% 59
2020
Q2 		$428K Buy
13,798
+1,958
+17% +$66.5K 0.1% 84
2020
Q1 		$367K Buy
11,840
+322
+3% +$11K 0.08% 76
2019
Q4 		$428K Buy
11,518
+515
+5% +$18.3K 0.54% 33
2019
Q3 		$375K Buy
+11,003
New +$400K 0.38% 37

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIA Investment Management's PFE Position: Q3 2020 in Review

AIA Investment Management increased its Pfizer (PFE) stake by 235% in Q3 2020, buying an estimated $1.14M and bringing the position to 46,289 shares worth $1.61M. The position accounts for 0.37% of the portfolio, ranked #59.

AIA Investment Management first reported a position in PFE in Q3 2019 and has held it in 5 quarters since. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • AIA Investment Management held 46,289 shares of Pfizer worth $1.61M as of Q3 2020.
  • AIA Investment Management bought 32,491 Pfizer shares in Q3 2020, an estimated $1.14M.
  • Pfizer made up 0.37% of AIA Investment Management's portfolio in Q3 2020, its #59 holding.
  • AIA Investment Management first reported a position in Pfizer in Q3 2019 and has held it in 5 quarters since.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.